Search volume for some version of "will AI replace medical writers" has grown steadily, and most answers to it are reassurance rather than argument. Here is the structural answer: under the rules that currently govern medical publishing, AI cannot hold the role, because the role is defined by accountability rather than by output.
The rule that settles it
The International Committee of Medical Journal Editors has required since May 2023 that authors disclose the use of AI-assisted technologies in manuscript preparation, and it explicitly prohibits listing AI as an author or co-author. The stated reasoning matters more than the prohibition: authorship carries responsibility for the integrity of the work, and a model cannot be responsible for anything.
That is not a temporary guardrail waiting for better models. It is a statement about what authorship is. A more capable model does not become more accountable. See the ICMJE recommendations and GPP 2022, which extends comparable transparency to medical-writing support across manuscripts, abstracts, posters, congress presentations and plain language summaries.
What AI genuinely does take over
The honest version is that a large share of the work does move — just not the part that defines the job.
- Screening. Title and abstract screening plus full-text extraction for a systematic review runs four to six weeks of subject-matter-expert time manually. With assisted retrieval and screening the initial pool can be cut by more than half within days.
- First drafts. Merck reported clinical study report authoring falling from two to three weeks to three to four days, with first-draft time dropping from 180 to 80 hours and errors halved.
- Consistency checking. Reference formatting, terminology, cross-document consistency — mechanical, high-volume, and where late-stage errors are most expensive.
- Review routing. Veeva reports up to a 75% reduction in MLR review cycle time with AI support.
Read that list again and notice what it has in common. Every item is handling — moving, sorting, formatting, drafting toward a template. None of it is judgement about whether a claim is supported by the data.
What it structurally cannot take
Three things, and they are the three that get you sued if they go wrong.
- Accountability for accuracy. Someone has to be answerable for whether the paper says what the data supports. ICMJE is explicit that this cannot be a model.
- Judgement about what to leave out. Most of the risk in medical writing is in what a document implies or omits, not in what it states. That is an editorial decision made against regulatory and ethical context.
- Handling the constraint itself. Wiley, Wolters Kluwer and Elsevier all warn against uploading unpublished manuscripts or patient data into general-purpose LLMs. Knowing which tool may touch which document is itself part of the job now.
The job that is actually at risk
There is a version of medical writing that AI does threaten, and pretending otherwise helps nobody: the role that is mostly formatting, mostly reformatting the same content for a different template, mostly assembling. That work was always undervalued and it is now cheap.
The role that gets more valuable is the one that was always the point — deciding what the evidence supports, spotting the claim that will not survive review, and taking responsibility for a document with a name on it. If screening drops from six weeks to days, the writer reaches the judgement sooner, and spends more of the project doing the part only a person can do.
What this means if you run a MedComms team
Two practical consequences.
First, start where no unpublished science is exposed. Publication trackers, MLR queues and congress calendars are process metadata — nothing sensitive leaves the building, the payback is visible, and you build the audit habits you will need before touching drafting. Roughly 88% of spreadsheets contain errors, and in this industry an error is a missed disclosure or a wrong version submitted.
Second, make the human sign-off structural rather than procedural. Not a policy line but a workflow that cannot advance without a named approval. In our clinical-NLP work that pattern produced 100% clinician sign-off on every summary while cutting discharge turnaround by 60%.
We have written the fuller picture in our guide to AI for medical publishing, and compared the tools by job in AI tools for medical publishing.